Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Non Operating Income: 2018-2024

Historic Non Operating Income for Arcturus Therapeutics Holdings (ARCT) over the last 7 years, with Dec 2024 value amounting to $15.2 million.

  • Arcturus Therapeutics Holdings' Non Operating Income fell 15.30% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.8 million, marking a year-over-year decrease of 37.52%. This contributed to the annual value of $15.2 million for FY2024, which is 8.41% down from last year.
  • As of FY2024, Arcturus Therapeutics Holdings' Non Operating Income stood at $15.2 million, which was down 8.41% from $16.6 million recorded in FY2023.
  • Over the past 5 years, Arcturus Therapeutics Holdings' Non Operating Income peaked at $16.6 million during FY2023, and registered a low of -$1.9 million during FY2021.
  • Its 3-year average for Non Operating Income is $10.5 million, with a median of $15.2 million in 2024.
  • In the last 5 years, Arcturus Therapeutics Holdings' Non Operating Income tumbled by 432.13% in 2021 and then spiked by 4,050.24% in 2023.
  • Yearly analysis of 5 years shows Arcturus Therapeutics Holdings' Non Operating Income stood at -$361,000 in 2020, then tumbled by 432.13% to -$1.9 million in 2021, then soared by 78.14% to -$420,000 in 2022, then spiked by 4,050.24% to $16.6 million in 2023, then declined by 8.41% to $15.2 million in 2024.